Team to study control of malaria-related parasite growth with $2.1-million NIH grant
Animal cells similar to those of humans contain a “control room,” called the centrosome, which regulates cell replication. Disrupt this core hub and you kill cell division. That […]
USF ENT part of leading study on an alternative sleep apnea therapy
–Study results published in recent New England Journal of Medicine- A recent New England Journal of Medicine article reporting that upper airway stimulation reduces […]
USF Health professor contributes to Lancet series on reducing research waste
A series of new papers in the journal Lancet discussing how to increase value and reduce waste in research includes a contribution by USF Distinguished Professor Benjamin Djulbegovic, […]
USF Health Heart Institute breaks ground [VIDEO]
Combining advanced research with the best care, the facility’s doctors and scientists will guide the way for new solutions to cardiovascular disease
New brief therapy eases symptoms of combat-related psychological trauma, USF Nursing study shows [VIDEO]
The research suggests Accelerated Resolution Therapy may be an option for veterans who do not respond optimally to conventional therapies endorsed by the Department of Defense and VA […]
USF global health researcher awarded Gates Foundation grant to tackle neglected parasitic diseases
Distinguished USF Health Professor Thomas Unnasch, PhD, was among the investigators to receive the latest Grand Challenges Explorations awards announced by Bill and Melinda Gates Foundation. Dr. Unnasch […]
Case studies by USF Health neurologists link smoking “spice” with stroke in healthy, young adults
Tampa, FL (Nov. 19, 2013) — Add stroke to the list of severe health hazards that may be associated with smoking synthetic marijuana, popularly known as spice or […]
USF Health faculty members honored for outstanding research
Four USF Health faculty members were among 11 recipients of the university’s 2013 Faculty Outstanding Research Achievement Awards. Cesario Borlongan, PhD; Chad Dickey, PhD; and Benjamin Djulbegovic, MD, […]
Edison, FARA and USF announce EPI-743 Phase 2 Friedreich’s ataxia clinical trial in adults with point mutations
First patient enrolled to evaluate investigational drug’s effectiveness in rare Friedreich’s ataxia genotype Mountain View, CA; Downingtown, PA; & Tampa, FL (Nov. 4, 2013) — Edison Pharmaceuticals, the […]
Byrd Institute CEO testifies before U.S. Senate Special Committee on Aging
Aging affects the risk of developing Alzheimer’s, heart disease, diabetes, cancer and other degenerative diseases as much as genetics and the environment, USF Health Byrd Alzheimer’s Institute CEO […]